Susquehanna International Group, LLP Relay Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$6.23 - $9.51 $388,129 - $592,473	62,300 New	62,300 $441,000
Q2 2023 Aug 11, 2023	BUY	$9.99 - $18.27 $515,484 - $942,732	51,600 Added 335.06%	67,000 $841,000
Q1 2023 May 16, 2023	SELL	$15.0 - $22.76 $357,000 - $541,688	-23,800 Reduced 60.71%	15,400 $253,000
Q4 2022 Feb 14, 2023	SELL	$14.16 - $24.02 $608,880 - $1.03 Million	-43,000 Reduced 52.31%	39,200 $585,000
Q3 2022 Nov 14, 2022	SELL	$18.07 - $31.37 $265,629 - $461,139	-14,700 Reduced 15.17%	82,200 $1.84 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $1.2 Million - $3.14 Million	89,900 Added 1284.29%	96,900 $1.62 Million
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $4,052 - $6,472	200 Added 2.94%	7,000 $210,000
Q4 2021 Feb 14, 2022	SELL	$26.0 - $37.03 $457,600 - $651,728	-17,600 Reduced 72.13%	6,800 $209,000
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $725,900 - $926,956	24,400 New	24,400 $769,000

204

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $500M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.